2. Academic Validation
  3. Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists

Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists

  • Bioorg Med Chem Lett. 2010 May 1;20(9):2903-7. doi: 10.1016/j.bmcl.2010.03.031.
John W Ullrich 1,  Robert Morris,  Ronald C Bernotas,  Jeremy M Travins,  James Jetter,  Rayomand Unwalla,  Elaine Quinet,  Ponnal Nambi,  Irene Feingold,  Christine Huselton,  Christofer Enroth,  Anna Wilhelmsson,  Annika Goos-Nilsson,  Jay Wrobel
Affiliations

Affiliation

  • 1 Chemical Sciences, Wyeth Pharmaceuticals, 500 Arcola Road, Collegeville, PA 19426, USA. JWUllrich@comcast.net
PMID: 20382019 DOI: 10.1016/j.bmcl.2010.03.031
Abstract

A series of 4-(3-biaryl)quinolines with sulfone substituents on the terminal aryl ring (8) was prepared as potential LXR agonists. High affinity LXRbeta ligands with generally modest binding selectivity over LXRalpha and excellent agonist potency in LXR functional assays were identified. Many compounds had LXRbeta binding IC(50) values <10 nM while the most potent had EC(50) values <1.0 nM in an ABCA1 mRNA induction assay in J774 mouse cells with efficacy comparable to T0901317. Sulfone 8a was further evaluated in LDL (-/-) mice and shown to reduce atherosclerotic lesion progression.

Figures